Meet the DM Drug Developers: Dyne Therapeutics

Meet the DM Drug Developers: Dyne’s Approach to Targeting DM1
February 5th, 2021
12:00 PM Pacific

Click Here to Register!

Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to learn more about Dyne Therapeutics.

Presenters will include Josh Brumm, Chief Executive Officer; Romesh Subramanian, PhD, Chief Scientific Officer; Chris Mix, MD, Senior Vice President, Clinical Development; and Molly White, Vice President, Medical Communications & Advocacy.

Click here to find all our upcoming Meet the DM Drug Developers dates!


Friday, February 5, 2021
Home / Meet the DM Drug Developers: Dyne Therapeutics

© Myotonic Dystrophy Foundation. All rights reserved.